Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently issued reports on the company. Barclays decreased their target price on Revance Therapeutics […]
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently issued reports on the company. Barclays decreased their target price on Revance Therapeutics […]
